Seoul, South Korea

Won Kyu Choi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Won Kyu Choi

Introduction: Won Kyu Choi is a prominent inventor based in Seoul, South Korea. He has made significant strides in the field of pharmaceuticals, particularly with his work on inclusion compounds. His innovative approach has the potential to impact cancer treatment and tumor metastasis inhibition.

Latest Patents: Won Kyu Choi holds a patent for "Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same." This invention relates to an inclusion compound of a fumagillol derivative or its salt with hydroxypropyl-β-cyclodextrin or sulfobutylether-7-β-cyclodextrin. The inclusion compound exhibits superior water solubility and stability while maintaining low toxicity, making it a valuable candidate as an anticancer agent or inhibitor of tumor metastasis. He has 1 patent to his name.

Career Highlights: Choi is associated with Chong Kun Dang Pharmaceutical Corporation, where he applies his expertise in pharmaceutical innovations. His work is instrumental in developing new therapeutic solutions that address critical health challenges.

Collaborations: Among his notable coworkers are Jae Hyun Kim and Su Kyung Lee, who contribute to the collaborative efforts in research and development within the company.

Conclusion: Won Kyu Choi's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in advancing cancer treatment options. His work continues to inspire future research and development in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…